Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03616327 · ClinicalTrials.gov registry record · NA
Workflow Validation of an In-Home Feedback Controlled Mandibular Positioner
A NA study, sponsored by Zephyr Sleep Technologies.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03616327: Completed NA study, sponsored by Zephyr Sleep Technologies.
NCT03616327 is a NA study that has completed, run by Zephyr Sleep Technologies. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03616327, a NA study, has completed, sponsored by Zephyr Sleep Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of the study is to test the workflow of the MATRx and MATRx plus feedback controlled mandibular positioner in its intended setting and considerations related to decision making by the care provider. The workflow includes the participant's recruitment into the study, the screening process, visits at the dentist, home sleep tests, and the decision made regarding oral appliance therapy based on the results of the sleep tests.
Primary Outcome
Evaluation of the process to effectively coordinate the respective roles in the deployment of the sleep test. Feasibility will be determined by the ability for patients to complete the MATRx plus test.
Interventions
- DEVICE MATRx in-lab, MATRx plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-08-19 |
| Phase | NA |
What the finished NCT03616327 record still lists
NCT03616327 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which MATRx in-lab, MATRx plus is the first listed.
NCT03616327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03616327 about?
NCT03616327 is a clinical study titled "Workflow Validation of an In-Home Feedback Controlled Mandibular Positioner". The purpose of the study is to test the workflow of the MATRx and MATRx plus feedback controlled mandibular positioner in its intended setting and considerations related to decision making by the care provider. The workflow includes the participant's recruitment into the study, the screening process...
What is the current status of trial NCT03616327?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-11-01. Estimated completion is 2019-08-19.
What interventions are being tested in trial NCT03616327?
The interventions under investigation include: MATRx in-lab, MATRx plus (DEVICE).
Who is sponsoring clinical trial NCT03616327?
This trial is sponsored by Zephyr Sleep Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03616327's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI